In a small classroom in Zimbabwe, a simple science class ignited my lifelong passion for biology and set me on a path to innovate treatments for high-impact diseases. This passion carried me through high school and pharmacy school in South Africa, where pharmacology became my favorite subject.During my master's in pharmaceutics, I developed a generic drug and used AI to aid drug development. This experience deepened my understanding of small molecules and motivated me to expand my expertise into biologics. Now, as I pursue a PhD in Biomedical and Pharmaceutical Sciences in the USA, I focus on developing lipid nanoparticle (drug) delivery systems for siRNA and CRISPR, targeting breast and prostate cancer.Creating innovative solutions in cancer treatment has inspired me to continue striving for novel solutions to improve patient outcomes globally. My journey also includes co-authoring a book chapter on AI in drug development, showcasing my work at the intersection of technology and pharmaceuticals.My education across three countries has given me a global and multicultural perspective that informs my approach to patient care and teamwork. Growing up in Zimbabwe, living in South Africa for a decade, and now studying and living in the United States of America, I have witnessed and experienced firsthand different healthcare systems, their good sides, and opportunities for improvement.This fueled my passion for contributing to global health outcomes by developing a collaborative biomedical innovation ecosystem at Artlin Health.